[1] El-Naggar AK, Chan JKC, Rubin Grandis J, et al. WHO classification of head and neck tumours. In:International Agency for Research on Cancer[M].4th Edition. 2017. [2] Wiscovitch A, Sifuentes-Cervantes JS, Porte JP, et al. Potential role of active decompression and distraction sugosteogenesis for the management of ameloblastomas: Report of two cases and review of the literature [J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2021:S2212-4403(21)00672-6. [3] Rapidis AD, Andressakis DD, Stavrianos SD, et al. Ameloblastomas of the jaws: clinico-pathological review of 11 patients [J]. Eur J Surg Oncol, 2004, 30(9):998-1002. [4] Menon S, Kumar V, Archana S, et al. Ameloblastoma management: "Horses for Courses" protocol [J]. J Maxillofac Oral Surg, 2019, 18(3):400-404. [5] 郭小科,刘冰,赵怡芳.76例单囊型成釉细胞瘤的回顾性分析[J].临床口腔医学杂志,2015,31(5):296-298. [6] 张文峰,赵怡芳,刘冰,等.成釉细胞瘤临床病理类型与预后[J].中华口腔医学杂志,2003,38(1):55. [7] 李铁军,吴运堂,于世凤,等.单囊型成釉细胞瘤的临床病理特点及其与复发的关系[J].中华口腔医学杂志,2002,37(3):210-212. [8] Yang Z, Liang Q, Yang L, et al. Marsupialization of mandibular cystic ameloblastoma: Retrospective study of 7 years [J]. Head Neck, 2018, 40(10):2172-2180. |